Dapeng Chen

Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

LGMN+ macrophage promotes the formation of a tumor-supportive microenvironment in gastric cancer.

LGMN+ macrophage promotes the formation of a tumor-supportive microenvironment in gastric cancer.

Journal: Frontiers in immunology

Published: February 13, 2026

Therapeutic Targeting of Oxidative Phosphorylation in Microsatellite Instability-High Gastric Cancer.

Therapeutic Targeting of Oxidative Phosphorylation in Microsatellite Instability-High Gastric Cancer.

Journal: Journal of Cancer

Published: October 23, 2025

Ultrasound-activated piezoelectric BZT Nanocubes mediate direct Piezocatalytic killing and reverse immunosuppressive tumor microenvironment for effective hepatocellular carcinoma therapy.

Ultrasound-activated piezoelectric BZT Nanocubes mediate direct Piezocatalytic killing and reverse immunosuppressive tumor microenvironment for effective hepatocellular carcinoma therapy.

Journal: International immunopharmacology

Published: October 15, 2025

Cholangiocarcinoma-derived SPP1 drives tumor progression by inducing macrophage chemotaxis and M2 polarization.

Cholangiocarcinoma-derived SPP1 drives tumor progression by inducing macrophage chemotaxis and M2 polarization.

Journal: International immunopharmacology

Published: June 02, 2025

ESCO2 promotes the proliferation of hepatocellular carcinoma through the PI3K/AKT/ mTOR signaling pathway.

ESCO2 promotes the proliferation of hepatocellular carcinoma through the PI3K/AKT/ mTOR signaling pathway.

Journal: Journal of Cancer

Published: February 13, 2025

Impaired mitochondrial degradation of CHCHD2 promotes metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma by upregulating VEGFA.

Impaired mitochondrial degradation of CHCHD2 promotes metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma by upregulating VEGFA.

Journal: Oncogene

Published: November 01, 2024

Integrative analysis based on ATAC-seq and RNA-seq reveals a novel oncogene PRPF3 in hepatocellular carcinoma.

Integrative analysis based on ATAC-seq and RNA-seq reveals a novel oncogene PRPF3 in hepatocellular carcinoma.

Journal: Clinical epigenetics

Published: August 18, 2024

TWEAK is an activator of Hippo-YAP signaling protecting against hepatic Ischemia/ reperfusion injury.

TWEAK is an activator of Hippo-YAP signaling protecting against hepatic Ischemia/ reperfusion injury.

Journal: International immunopharmacology

Published: July 31, 2024

Revealing the crosstalk between LOX+ fibroblast and M2 macrophage in gastric cancer by single-cell sequencing.

Revealing the crosstalk between LOX+ fibroblast and M2 macrophage in gastric cancer by single-cell sequencing.

Journal: BMC cancer

Published: June 26, 2024

A necroptosis-regulated model from single-cell analysis that predicts survival and identifies the Pivotal role of MAGEA6 in hepatocellular carcinoma.

A necroptosis-regulated model from single-cell analysis that predicts survival and identifies the Pivotal role of MAGEA6 in hepatocellular carcinoma.

Journal: Heliyon

Published: June 25, 2024

Single-cell analysis reveals the immune heterogeneity and interactions in lungs undergoing hepatic ischemia-reperfusion.

Single-cell analysis reveals the immune heterogeneity and interactions in lungs undergoing hepatic ischemia-reperfusion.

Journal: International immunopharmacology

Published: July 12, 2023

ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.

ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.

Journal: BMC cancer

Published: April 04, 2023

Showing 1-12 of 15

Last Updated: 09/26/2026